Intravenous Dexmedetomidine for Emergence Delirium in Pediatric Patient

Clinical trial NCT05813106 · UNKNOWN

Trial details

NCT number: NCT05813106
Sponsor: Security Forces Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Emergence Delirium Dexmeditomidine

Start date: 2022-12-01
Primary completion: 2023-04-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.